» Articles » PMID: 10229849

The Substance P Receptor is Necessary for a Normal Granulomatous Response in Murine Schistosomiasis Mansoni

Overview
Journal J Immunol
Date 1999 May 7
PMID 10229849
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Immune cells within the granulomas of murine schistosomiasis mansoni make the neuropeptide substance P (SP) and express neurokine 1 receptor, which is the specific receptor for substance P (SPr). It was determined if mice with deletion of the SPr (SPr-/-) would develop a normal granulomatous response to schistosome ova during the course of natural infection. Mean liver granuloma size was smaller in SPr-/- mice compared with that of wild-type control animals. Although flow analysis revealed little difference in the cellular composition of the granulomas, both splenocytes and granuloma cells from SPr-/- mice produced much less IFN-gamma and IgG2a and less IgE. The expression of Th2 cytokines (IL-4/IL-5) and IgG1 was comparable to the wild-type control. The mouse with targeted disruption of its SPr had the nonmammalian gene encoding the enzyme beta-galactosidase inserted in exon 1 of the SPr gene. There was beta-galactosidase activity in many mononuclear cells scattered throughout the schistosome granulomas of SPr-/- mice. Also, a granuloma T cell line derived from this transgenic mouse produced beta-galactosidase. These results provide further evidence that in murine schistosomiasis SPr is displayed commonly on granuloma inflammatory cells and is important for granuloma development and expression of IFN-gamma circuitry in this natural infection.

Citing Articles

Mammalian Neuropeptides as Modulators of Microbial Infections: Their Dual Role in Defense versus Virulence and Pathogenesis.

Augustyniak D, Kramarska E, Mackiewicz P, Orczyk-Pawilowicz M, Lundy F Int J Mol Sci. 2021; 22(7).

PMID: 33915818 PMC: 8036953. DOI: 10.3390/ijms22073658.


Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.

Suvas S J Immunol. 2017; 199(5):1543-1552.

PMID: 28827386 PMC: 5657331. DOI: 10.4049/jimmunol.1601751.


Substance P receptor antagonism: a potential novel treatment option for viral-myocarditis.

Robinson P, Taffet G, Engineer N, Khumbatta M, Firozgary B, Reynolds C Biomed Res Int. 2015; 2015:645153.

PMID: 25821814 PMC: 4363507. DOI: 10.1155/2015/645153.


Prophylactic and therapeutic targeting of the neurokinin-1 receptor limits neuroinflammation in a murine model of pneumococcal meningitis.

Chauhan V, Kluttz J, Bost K, Marriott I J Immunol. 2011; 186(12):7255-63.

PMID: 21562162 PMC: 3110637. DOI: 10.4049/jimmunol.1100721.


TGF-beta regulates T-cell neurokinin-1 receptor internalization and function.

Beinborn M, Blum A, Hang L, Setiawan T, Schroeder J, Stoyanoff K Proc Natl Acad Sci U S A. 2010; 107(9):4293-8.

PMID: 20160079 PMC: 2840170. DOI: 10.1073/pnas.0905877107.